Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Olli Aaltonen is active.

Publication


Featured researches published by Olli Aaltonen.


Journal of Supercritical Fluids | 2002

The effect of initial drop size on particle size in the supercritical antisolvent precipitation (SAS) technique

Markku Rantakylä; Matti Jäntti; Olli Aaltonen; Markku Hurme

The objective of this study was to find the effect of the initial droplet size on the final particle size in the semi-continuous SAS technique. In this technique the solute of interest is first dissolved in a conventional solvent. Particle formation is accomplished by spraying this solution continuously through a nozzle into a chamber containing subcritical or supercritical carbon dioxide. The droplet sizes were calculated from four alternative equations. The theoretical particle sizes were calculated from the calculated droplet sizes assuming that one agglomerated microparticle is produced from each droplet. The theoretical mean particle sizes and the measured particle sizes were compared. The particle formation model was tested with poly(l-lactid acid) (l-PLA) in dichloromethane (DCM) and carbon dioxide. The smallest l-PLA particles were formed by spraying l-PLA/DCM solution into liquid CO2 below 304 K and 8.0 MPa. Under these conditions, the mean agglomerate particle diameter was less than 4 μm. When spraying the solution into supercritical CO2 at 308–323 K and 10–14 MPa, the mean particle size was 8–14 μm. Higher temperatures and pressures increased the mean particle size. The particles were strongly agglomerated at the highest temperature and pressure (333 K and 17 MPa). Recrystallization of l-PLA into small particles is possible below 308 K and 10 MPa using the SAS technique. According to the droplet formation models, the effects of temperature, pressure, CO2 velocity and density, nozzle diameter, interfacial tension between liquid and CO2, and Reynolds and Weber numbers on the droplet size is small. The calculated theoretical particle size agreed reasonably well with the final particle size at the near critical temperature and pressure of CO2. However, the droplet and particle formation models did not explain the observed changes of particle sizes with changes in operating conditions. It is suggested that the initial droplet sizes, formed at the nozzle, do not have an effect on the final particle size.


Biotechnology Letters | 1994

Enantioselective esterification of ibuprofen in supercritical carbon dioxide by immobilized lipase

Markku Rantakylä; Olli Aaltonen

The enantioselective esterification of racemic ibuprofen with n-propanol by immobilized Mucor miehel lipase in supercritical carbon dioxide was studied. The enantiomeric excess of the product (eep) was 70 % at 15...20 % conversion. The enantioselectivity was faintly affected by temperature and the concentration of ibuprofen and lipase. The optimum temperature was 45 °C. The initial reaction rate increased with pressure, but enantioselectivity was not affected by pressure changes. The reaction rates in supercritical carbon dioxide at optimized conditions and in n-hexane were similar.


Biotechnology Letters | 1996

Stereospecific hydrolysis of 3-(4-methoxyphenyl)glycidic ester in supercritical carbon dioxide by immobilized lipase

Markku Rantakylä; Martti Alkio; Olli Aaltonen

In the hydrolysis of racemic 3-(4-methoxyphenyl)glycidic acid methyl ester by immobilized Mucor miehel lipase in supercritical CO2 the initial hydrolysis rate of the (2S,3R)-form was faster than the rate of the (2R,3S) -form. The stereoisomeric excess of the (2R,3S)-form reached 87 % at 53 % total conversion level. The water content of the reaction mixture and the initial concentration of the 3-(4-methoxyphenyl) glycidic acid methyl ester had no effect on isomeric purity. The reaction rate in supercritical CO2 was considerably faster than in toluene/water -mixture.


Green Chemistry | 2013

Continuous catalyst-free aromatization of γ-terpinene using air as an oxidant

Martta Asikainen; Olli Jauhiainen; Olli Aaltonen; Ali Harlin

The dehydrogenation of γ-terpinene was studied under catalyst- and solvent-free reaction conditions using air as an oxidant. The dehydrogenation affords p-cymene in good yields in a continuous flow reaction setup. The initial optimization of the reaction parameters showed that the dehydrogenation is highly dependent on the vapour/liquid phase equilibrium and the availability of oxygen in the vapour phase.


Carbohydrate Polymers | 2009

The preparation of lignocellulosic aerogels from ionic liquid solutions

Olli Aaltonen; Olli Jauhiainen


Chemtech | 1991

BIOCATALYSIS IN SUPERCRITICAL CO2

Olli Aaltonen; Markku Rantakyla


Organic Process Research & Development | 2000

Solubility of Fluorinated Pharmaceuticals in Dense Carbon Dioxide

Antero Laitinen; and Olli Jauhiainen; Olli Aaltonen


Organic Process Research & Development | 2005

Unusual nazarov cyclization in near-critical water

Tuomo Leikoski; Juha Kaunisto; Martti Alkio; Olli Aaltonen; Jari Yli-Kauhaluoma


Archive | 2000

Method for purifying phytosterol concentrates using a pressurized fluid (carbon dioxide)

Olli Aaltonen; Sampsa Haarasilta; Pekka Piiroinen; Markku Rantakylä; Jouko Virtanen; Antti Kaipainen


Archive | 1996

Chromatographic purification of cyclosporing using a high pressure carbon dioxide eluent

Juhani Lundell; Jarkko Ruohonen; Olli Aaltonen; Martti Alkio; Anneli Hase; Tapani Suortti

Collaboration


Dive into the Olli Aaltonen's collaboration.

Top Co-Authors

Avatar

Martti Alkio

VTT Technical Research Centre of Finland

View shared research outputs
Top Co-Authors

Avatar

Anneli Hase

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Markku Rantakylä

VTT Technical Research Centre of Finland

View shared research outputs
Top Co-Authors

Avatar

Antero Laitinen

VTT Technical Research Centre of Finland

View shared research outputs
Top Co-Authors

Avatar

Jarkko Ruohonen

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Juhani Lundell

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar

Tapani Suortti

SANTEN PHARMACEUTICAL CO.

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Olli Jauhiainen

VTT Technical Research Centre of Finland

View shared research outputs
Researchain Logo
Decentralizing Knowledge